Drop has occurred on relatively low volume (volume today represents 0.2% of issued capital) - indicates lack of interest in IDL as much as anything with private traders stopping out.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025